U.S. Markets open in 7 hrs 43 mins

Weibo (WB) Surges: Stock Moves 8.1% Higher

Zacks Equity Research

Weibo Corporation WB was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 17.7% in the past one-month time frame.

The company has seen one negative estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Weibo currently has a Zacks Rank #4 (Hold) while its Earnings ESP is negative.

Weibo Corporation Price

Weibo Corporation Price | Weibo Corporation Quote

Investors interested in the Internet – Content industry may consider Brightcove Inc. BCOV, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is WB going up? Or down? Predict to see what others think: Up or Down

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Weibo Corporation (WB) : Free Stock Analysis Report
 
Brightcove Inc. (BCOV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research